26.09.2019 Media release

BIOCAD and Shanghai Pharma Holding finalized the deal to establish a joint venture in China

On September the 17th, during a ceremony in Constantine’s Palace, Russian Prime Minister Dmitry Medvedev and Premier of the State Council of the People’s Republic of China Li Keqiang witnessed the signing of final agreement between BIOCAD and Shanghai Pharma Holding to establish a joint venture between the two high-visibility players in order to bring more advanced biological products to China.

The deal was signed by the BIOCAD's founder and CEO Dmitry Morozov on behalf of the Russian company, and the Chinese part was represented by its Chairman Mr. Jun Zhou. BIOCAD names Shanghai Pharma the exclusive partner in China, opening access to certain current and future high-tech innovative therapeutics researched at BIOCAD.